Gemphire Therapeutics is a startup based in the United States.
Gemphire Therapeutics is a company headquartered in the United States.
Gemphire Therapeutics develops treatments addressing unmet medical needs in patients with Painful Diabetic Neuropathy (PDN) and Alzheimer’s disease following a merger with NeuroBo Pharmaceuticals in 2019.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.